Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...

Replimune Group (REPL) is scheduled to report Q1 earnings on August 6, 2026. Analysts estimate EPS of $-0.62 and quarterly revenue of $7.53M. Over the last 4 quarters, Replimune Group has averaged an ...

Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...

If Mayor Brandon Johnson were to pull off a parking meter buyback and improve the ...

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip ...